Lifeline Pharma AS – Trademark Portfolio

Entity Type: 99

Lifeline Pharma AS holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 5 Nice Classification classes.

Klingenberggata 4

N-0161 OSLO

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Lifeline Pharma AS's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

29
Meats & Processed Foods (1 filing)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Lifeline Pharma AS have?

Lifeline Pharma AS has 1 U.S. trademark filed with the USPTO.

What trademark classes does Lifeline Pharma AS file in?

Lifeline Pharma AS files trademarks across 5 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 29 (Meats & Processed Foods), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is Lifeline Pharma AS's trademark registration success rate?

Lifeline Pharma AS has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.